Evidence map›Paper›PMID 42100008›Full record

ArticleEuropean clinical respiratory journal2026

Cystic fibrosis mental health and wellness questionnaire - factors and properties of a comprehensive CF-specific self-report measure.

C Virginia O'Hayer, Patrick J Smith, Max J Genecov, Christopher F Drescher, Heather Bruschwein, Chelsi N Nurse, Katherine Lawliss, Darcy C Esiason, Gunnar H Esiason

Abstract read
In one paragraph

Article in European clinical respiratory journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

C Virginia O'HayerDepartment of Psychiatry & Human Behavior, Thomas Jefferson University Hospital, Philadelphia, PA, USA.
Patrick J SmithDepartment of Psychiatry, University of North Carolina - Chapel Hill, North Carolina, USA.
Max J GenecovDepartment of Psychiatry & Human Behavior, Thomas Jefferson University Hospital, Philadelphia, PA, USA.
Christopher F DrescherDepartment of Psychiatry and Health Behavior, Augusta University, Augusta, Georgia.
Heather BruschweinDepartment of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, Virginia, USA.
Chelsi N NurseDepartment of Psychiatry & Human Behavior, Thomas Jefferson University Hospital, Philadelphia, PA, USA.
Katherine LawlissQuince Orchard Psychotherapy, Rockville, Maryland, USA.
Darcy C EsiasonEsiason O'Hayer Institute for Behavioral Medicine Bryn Mawr, Pennsylvania, USA.
Gunnar H EsiasonBoomer Esiason Foundation, New York, New York, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Existing mental health self-report measures have been criticized for over-simplification, lack of CF-specific focus, susceptibility to measurement reactivity bias, and conflation of symptoms of anxiety and/or depression with CF-related symptoms and/or treatment side effects. The CF Mental Health and Wellness Questionnaire (CFMHWQ) is a 25-item measure assessing CF-specific mental health burden symptoms. Methods: To examine common underlying factors contributing to scores on the CFMHWQ, principal component analysis (PCA) was conducted of all 25 items. We conducted cross-validation of CFMHWQ principal components, examining unadjusted correlations between each principal component, demographic characteristics (age and biological sex), negative affect (mean rank global score combining BDI-II and BAI), psychological flexibility (mean rank global score combining AAQ-II and CFQ), and clinical characteristics. Results: One hundred twenty-three individuals contributed data for the PCA. A 5-factor model provided the most interpretable structure. Factors appeared to correspond to CF role-related concerns, CF symptomatic burden, social impairments due to CF, behavioral compliance, and coping/personality factors. Greater CF role impairments, behavioral adherence, symptom burden, social impairments, and poorer CF coping are all associated with greater negative affect. Similarly, greater levels of psychological flexibility are associated with lower CF role impairments, social impairments, behavioral adherence, and higher CF coping. Older age was associated with better behavioral adherence, but otherwise demographic factors were unrelated to CFMHWQ scores. Conclusions: The CFMHWQ is a promising new self-report measure of CF-specific mental health burden, which associates with negative affect and psychological flexibility. Older age was associated with better behavioral adherence. Finally, more than half reported having undergone a medical procedure they experienced as traumatic, highlighting the importance of measuring the mental health burden of CF. Given the CF-specific nature of items and overfamiliarity with existing measures, we encourage the addition of the CFMHWQ by the CF community.

Indexed as

CF-specific mental health burdencoping with cystic fibrosisCystic fibrosismental health and wellnessself-report measure

Identifiers

PMID42100008
PMCPMC13148087

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.